PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.

Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 63 results · Obesity & Weight Management  · Clear
🔒 Subscribers only
AUTH/3890/4/24
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Three articles in the business section of a national newspaper were based on an interview with a senior employee of Novo Holdings (controlling shareholder of Novo Nordisk A/S). The articles were …
Clauses: NONE
🔒 Subscribers only
AUTH/3754/3/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A concerned health professional found that a booking form for a “Free Weight Management Course (WEBINAR + PGD)” was still accessible online via a specific Google search term.The form related to…
Clauses: NONE
🔒 Subscribers only
AUTH/3755/3/23
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A health professional alleged Novo Nordisk had funded the salary of a named obesity practitioner at a named hospital as an inducement to prescribe Novo Nordisk medicines (liraglutide and semaglutid…
Clauses: NONE
🔒 Subscribers only
AUTH/3752/3/23
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk voluntary admission
The PMCPA Director took up a complaint following five Observer articles (print/online, 12 March 2023 and 2 April 2023) critical of Novo Nordisk’s activities around semaglutide for weight loss (We…
Clauses: NONE
🔒 Subscribers only
AUTH/3763/4/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Two academic complainants raised concerns about Novo Nordisk’s Disclosure UK reporting and third-party activities linked to a training provider and a pharmacy services provider. Transfers of valu…
Clauses: NONE
🔒 Subscribers only
AUTH/3821/9/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous health professional complained about Saxenda (liraglutide 3mg) in the context of GLP-1 supply shortages and alleged Novo Nordisk continued to promote Saxenda despite supply issues.The …
Clauses: NONE
🔒 Subscribers only
AUTH/3865/12/23
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An ex-employee complained about a Novo Nordisk promotional meeting for Wegovy held in Scotland on 04–05 November 2022.The complainant alleged Wegovy did not have a marketing authorisation (MA) in…
Clauses: NONE
🔒 Subscribers only
AUTH/3867/12/23
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code after employee reposted Financial Times LinkedIn post mentioning Weg
An anonymous, non-contactable complainant (self-described health professional) raised concerns about a Novo Nordisk employee’s LinkedIn activity involving a Financial Times (FT) post.The employee…
🔒 Subscribers only
AUTH/3737/2/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Saxenda leavepiece
A health professional complained about a Saxenda (liraglutide) promotional leavepiece (UK20SX00030), described as an “HCP discussion guide”. The complainant alleged the leavepiece was freely av…
Clauses: NONE
🔒 Subscribers only
AUTH/3738/2/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission after an internal investigation linked to Case AUTH/3711/11/22.The issue concerned a weight management and obesity “hub” hosted on a named UK pharmacists…
Clauses: NONE
🔒 Subscribers only
AUTH/3717/12/22
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Public complaint about weight-loss media coverage
A member of the public complained that five media articles about weight loss effectively promoted Novo Nordisk prescription-only medicines (including Wegovy/Ozempic) to the public as a safe way to …
Clauses: NONE
🔒 Subscribers only
AUTH/3604/1/22
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK-based individual contracted to work for Novo Nordisk A/S (via a third-party talent acquisition company) posted on LinkedIn (approx. June 2021).The post referenced a planned phase 3a trial of �…
Clauses: NONE
🔒 Subscribers only
AUTH/3640/5/22
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission about a promotional email to health professionals stating Novo Nordisk UK had no issues with supply of Ozempic (semaglutide) and Rybelsus (semaglutide) (GLP-…
Clauses: 9.1
🔒 Subscribers only
AUTH/3711/11/22
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached Clause 5.5 over unclear involvement in pharmacist obesity hub and documents (A
A UK health professional complained about a password-protected weight management and obesity “hub” hosted on a UK pharmacist association’s website, developed under a Collaborative Working (CW…
Clauses: NONE
🔒 Subscribers only
AUTH/3653/5/22
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Eli Lilly complained about promotional emails sent by Novo Nordisk to health professionals about GLP-1 receptor agonist (GLP-1RA) supply during a temporary stock outage of higher-dose Trulicity (du…
Clauses: NONE
🔒 Subscribers only
AUTH/3456/1/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Boehringer Ingelheim & Eli Lilly
Clauses: NONE
🔒 Subscribers only
AUTH/3545/7/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached Clause 5.1 after listing an 0845 number for side-effect reporting on Saxenda p
A UK health professional complained that the Saxenda (liraglutide) patient website (www.saxenda.co.uk) listed an 0845 telephone number under “Reporting of side effects” for reporting adverse ev…
Clauses: NONE
🔒 Subscribers only
AUTH/3483/3/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eli Lilly
A UK health professional complained about a LinkedIn post about an investigational medicine being ‘liked’ by UK-based staff, allegedly promoting it to the UK public.The post was on the Eli Lill…
Clauses: NONE
🔒 Subscribers only
AUTH/3523/6/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK health professional complained about a LinkedIn post made (June 2021) by an individual contracted to work for Novo Nordisk A/S (Denmark) via a third-party talent acquisition agency.The post st…
Clauses: NONE
🔒 Subscribers only
AUTH/3543/7/21
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eli Lilly
Novo Nordisk complained about Eli Lilly’s promotional presentation, ‘Barber’s Box comparison of GLP‑1 receptor agonists’ (PP-DG-GB-0573, January 2020), used to compare dulaglutide (Trulic…
Clauses: NONE
🔒 Subscribers only
AUTH/3525/6/21
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK health professional complained about a LinkedIn post by a clinical training provider advertising a FREE weight management webinar with “funding to get you started”. The LinkedIn post linke…
Clauses: 3.2,9.1
🔒 Subscribers only
AUTH/3445/12/20
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk Ozempic email alleged off-label promotion to under-18s (No breach)
A health professional complained about a Novo Nordisk promotional email for Ozempic (semaglutide) (ref UK20OZM00311) sent via Pulse.The email referenced SUSTAIN 7 data and included claims such as �…
Clauses: NONE
🔒 Subscribers only
AUTH/3427/11/20
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Eli Lilly complained about two Novo Nordisk slide decks on cardiovascular outcome trials (CVOTs) in type 2 diabetes (refs UK19OZM00368 Nov 2019 and UK20DI00110 April 2020). The complaint focused on…
Clauses: NONE
🔒 Subscribers only
AUTH/3315/3/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An individual complained about two LinkedIn posts about obesity made by Novo Nordisk employees around World Obesity Day 2020.The posts included pledges such as “Help stamp out weight stigma”, �…
Clauses: NONE
1 2 3 Next → Page 1 of 3 — 63 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews